117703-84-1

Basic information

• Product Name: 2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid
• CAS NO: 117703-84-1
• Molecular Formula: C₇H₁₁NO₇
• Molecular Weight: 221.1647
• Mol File: 117703-84-1.mol
• Article Data: 0

Chemical Properties

• Density: 1.641g/cm³
• Refractive Index: 1.57
• CAS DataBase Reference: 2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid(117703-84-1)
• EPA Substance Registry System: 2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid(117703-84-1)

Safety Data

• Hazardous Substances Data: 117703-84-1(Hazardous Substances Data)

Usage

Description

2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid, also known as Nebramine A, is a naturally occurring compound that belongs to the nebramycin group of aminoglycoside antibiotics. It is derived from a marine bacterium and has demonstrated potential as an antibiotic with activity against a wide range of Gram-positive and Gram-negative bacteria, including drug-resistant strains. 2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid has shown promising results in preclinical trials and has been found to exhibit low toxicity in animal studies, making it a candidate for further development as a therapeutic agent.

Uses

Used in Antibacterial Applications:
2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid is used as an antibiotic for treating bacterial infections, particularly those caused by Gram-positive and Gram-negative bacteria. Its broad-spectrum activity makes it a valuable tool in combating drug-resistant strains, which is a growing concern in the medical field.
Used in Drug-Resistant Infections:
2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid is used as a potential treatment for antibiotic-resistant infections. Its effectiveness against drug-resistant strains has shown promising results in preclinical trials, indicating that it could be a valuable addition to the arsenal of antibiotics available for treating such infections.
Used in Therapeutic Agent Development:
2,3-dideoxy-4-C-(hydroxycarbamoyl)-3-methylpentaric acid is used as a candidate for further development as a therapeutic agent. Its low toxicity in animal studies, combined with its potential as an antibiotic, makes it a promising compound for the development of new treatments for bacterial infections.